Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry.
|
J Clin Endocrinol Metab
|
2009
|
2.01
|
2
|
Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial.
|
Br J Psychiatry
|
2012
|
1.87
|
3
|
Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial.
|
J Clin Endocrinol Metab
|
2008
|
1.79
|
4
|
Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men.
|
J Hypertens
|
2005
|
1.75
|
5
|
Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study.
|
Nutr Metab Cardiovasc Dis
|
2007
|
1.62
|
6
|
Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø study.
|
J Neurol
|
2005
|
1.49
|
7
|
Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels.
|
Thromb Haemost
|
2009
|
1.42
|
8
|
Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromsø Study.
|
J Clin Endocrinol Metab
|
2004
|
1.34
|
9
|
Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study.
|
PLoS One
|
2012
|
1.23
|
10
|
Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone.
|
Eur J Endocrinol
|
2009
|
1.19
|
11
|
Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study.
|
Eur J Endocrinol
|
2009
|
1.19
|
12
|
Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men.
|
Eur J Endocrinol
|
2010
|
1.18
|
13
|
The serum 25-hydroxyvitamin D response to vitamin D supplementation is related to genetic factors, BMI, and baseline levels.
|
Eur J Endocrinol
|
2013
|
1.13
|
14
|
Incidence of and risk factors for type-2 diabetes in a general population: the Tromsø Study.
|
Scand J Public Health
|
2010
|
1.10
|
15
|
Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway.
|
Eur J Endocrinol
|
2010
|
1.05
|
16
|
High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency.
|
Clin Endocrinol (Oxf)
|
2011
|
1.02
|
17
|
Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death.
|
Eur J Endocrinol
|
2008
|
0.98
|
18
|
Risk factors for type 2 diabetes in groups stratified according to metabolic syndrome: a 10-year follow-up of the Tromsø Study.
|
Eur J Epidemiol
|
2010
|
0.97
|
19
|
Androgen receptor gene polymorphism and the metabolic syndrome in 60-80 years old Norwegian men.
|
Int J Androl
|
2008
|
0.86
|
20
|
Plasma profile of microRNA after supplementation with high doses of vitamin D3 for 12 months.
|
BMC Res Notes
|
2012
|
0.86
|
21
|
Impact of testosterone treatment on postprandial triglyceride metabolism in elderly men with subnormal testosterone levels.
|
Scand J Clin Lab Invest
|
2008
|
0.85
|
22
|
Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency.
|
Eur J Endocrinol
|
2012
|
0.85
|
23
|
Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.84
|
24
|
Six months of diazoxide treatment at bedtime in newly diagnosed subjects with type 1 diabetes does not influence parameters of {beta}-cell function and autoimmunity but improves glycemic control.
|
Diabetes Care
|
2009
|
0.83
|
25
|
Testosterone levels and psychological health status in men from a general population: the Tromsø study.
|
Aging Male
|
2010
|
0.83
|
26
|
Testosterone, hemostasis, and cardiovascular diseases in men.
|
Semin Thromb Hemost
|
2011
|
0.81
|
27
|
Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cure.
|
Clin Endocrinol (Oxf)
|
2011
|
0.81
|
28
|
Associations between polymorphisms related to calcium metabolism and human height: the Tromsø Study.
|
Ann Hum Genet
|
2012
|
0.80
|
29
|
Plasma free tissue factor pathway inhibitor (TFPI) levels and TF-induced thrombin generation ex vivo in men with low testosterone levels.
|
Thromb Haemost
|
2009
|
0.79
|
30
|
Estrogen receptor alpha single nucleotide polymorphism as predictor of diabetes type 2 risk in hypogonadal men.
|
Aging Male
|
2013
|
0.79
|
31
|
[Treatment practice in primary hyperparathyroidism].
|
Tidsskr Nor Laegeforen
|
2009
|
0.78
|
32
|
Effects of Age and Sex on Estimated Diabetes Prevalence Using Different Diagnostic Criteria: The Tromsø OGTT Study.
|
Int J Endocrinol
|
2013
|
0.78
|
33
|
Postprandial triglyceride metabolism in elderly men with subnormal testosterone levels.
|
Asian J Androl
|
2008
|
0.78
|
34
|
Androgen receptor gene polymorphism and sex hormones in elderly men: the Tromsø study.
|
Asian J Androl
|
2009
|
0.77
|
35
|
Change in cardiovascular risk factors in relation to diabetes status: the Tromso Study.
|
Eur J Prev Cardiol
|
2011
|
0.76
|
36
|
[Endogenous Cushing's syndrome].
|
Tidsskr Nor Laegeforen
|
2006
|
0.75
|
37
|
[Hormonally inactive pituitary adenomas].
|
Tidsskr Nor Laegeforen
|
2003
|
0.75
|
38
|
The phosphodiesterase 8B gene rs4704397 is associated with thyroid function, risk of myocardial infarction, and body height: the Tromsø study.
|
Thyroid
|
2013
|
0.75
|
39
|
[Primary adrenal failure--causes, diagnostics and therapy].
|
Tidsskr Nor Laegeforen
|
2005
|
0.75
|